Delivery Order SPE2DB22D2206-SPE2DB24FJL45
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,159.02, is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a ceiling value of $28,487.26 and is a firm fixed price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,207.10 contract is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medical product, with a period of performance through June 30, 2025. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division for the procurement of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract has a ceiling value of $19,331.43 and a period of performance ending on April 25, 2024. This award is made under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,215.41, is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,264.66, is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm-fixed-price delivery order (SPE2DB24D1205|SPE2DB25FCQST) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4566074973 - BARHEMSYS 10 MG/4 ML VIAL 4ML. The $2,676.38 order has an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds indefinite delivery contracts (IDCs) with the DLA and Department of Justice valued up to $999,999,999 and $750,000 respectively for delivering a range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BARHEMSYS, a medication used to treat postoperative nausea and vomiting, with a ceiling value of $21,784.03 and a performance period through April 2025. The contract is not set aside and is a firm-fixed-price delivery order, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award is for the pharmaceutical product BARHEMSYS 5 MG/2 ML VIAL 2ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,429.69 firm-fixed-price delivery order has a completion date of September 22, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This is a $29,326.23 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment. The contract has an ultimate completion date of July 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, leverages its extensive supply chain...